article thumbnail

12 Medications With Off-Label Uses

BuzzRx

The term “on-label use” of a drug may seem unfamiliar to most people. In short, this practice is referred to as “off-label” drug use. Surveys have shown that approximately 1 in 5 prescriptions in the US are for off-label use. In certain populations of patients, off-label drug use is even higher.

article thumbnail

First UK-licensed melatonin for children with insomnia and ADHD

European Pharmaceutical Review

However until now, prescribing a treatment for children with ADHD has been off-label or unlicensed in the UK. AGB-Pharma , the Swedish pharmaceutical company that produced the drug, predicted around 60 percent of all melatonin prescriptions are dispensed to under 18s off-label or unlicensed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Complete guide on pharmaceutical medical affairs

Viseven

They provide information about the following: Off-label usage Publications Safety information Independent medical education. Under its internal affairs, the pharmaceutical ones bring together the research and commercial wings of the pharma businesses. The role of medical affairs in pharmaceutical companies.

article thumbnail

Meet the 2023 Social Impact Category Winner: Takeda SA

ISPE

Takeda is the first pharmaceutical company worldwide to have implemented this water preservation project, in collaboration with a Belgian start-up Ekopak, on a large scale. Their overall goal is to reduce freshwater withdrawal by 90% by 2027 (the equivalent of 600 million liters of freshwater).

article thumbnail

ChatGPT, BARD, and Other Large Language Models Meet Regulated Pharma

ISPE

In sections where we applied ChatGPT for example cases, we indicate this as such: The question or remark from us is labeled as Authors. In regulated areas, information should always be validated and verified by a qualified healthcare professional before being used in patient care or treatment decisions.

article thumbnail

Legal challenges put off label use of gender affirming care drugs in jeopardy

Pharmaceutical Technology

Barry DeCoster, PhD, an associate professor of bioethics at the University of Michigan, describes gender affirming care as “safe and effective” for most patients. Most drugs used here are prescribed off-label, and experts say pharmaceutical companies remain hesitant to conduct clinical trials studying gender-affirming care.

Labelling 144